Skip to main content

Searching for a Vaccine Against an Ancient Scourge

September 19, 2024
With data from one of the most extensive genomic surveys of the syphilis bacterium – correlated with clinical information from patients – an international team of researchers and doctors are on the hunt for proteins on the surface of the microbe that don’t vary and could be good targets for...

Parr Elected to the American Society for Clinical Investigation

December 21, 2023
Jonathan Parr, MD, MPH, assistant professor medicine and researcher with the Institute for Global Health and Infectious Diseases, has been elected to the American Society for Clinical Investigation (ASCI), a nonprofit medical honor society that seeks to seeks to support the scientific efforts, educational needs, and clinical aspirations of physician-scientists...

Assefa, Parr Review a Novel Strategy for Eliminating Malaria, Published in The Lancet

November 15, 2023
Post-doctoral fellow Ashenafi Assefa, PhD, and Jonathan Parr, MD, MPH, assistant professor of medicine in infectious diseases, researchers with the Institute for Global Health and Infectious Diseases (IGHID) working in the IDEEL (the Infectious Disease Epidemiology and Ecology) Lab assess the pros and cons of a new strategy to simplify malaria...

IAMIGHID: The Infectious Disease Epidemiology and Ecology Lab (IDEEL)

October 29, 2023
Researchers in the Infectious Disease Epidemiology and Ecology Lab (IDEEL) at UNC are process driven investigators with a unique comradery, working in 20+ countries to improve basic understandings of pathogens. The applied nature of their work has a direct impact on the health and well-being of millions of individuals around...

Malaria-Causing Parasites Resistant to Both Treatment and Detection Emerge in Ethiopia

October 17, 2023
Researchers with the Institute for Global Health and Infectious Diseases (IGHID) through IDEEL (the Infectious Disease Epidemiology and Ecology Lab), have detected new strains of malaria-causing parasites in Ethiopia that are both resistant to current treatments and escape detection by common diagnostic tests. Jonathan Parr, MD, MPH, IGHID member and...

UNC School of Medicine’s Institute for Global Health and Infectious Diseases Receives $2.9 Million Capacity Building Grant for Malaria Surveillance in the Democratic Republic of the Congo

April 25, 2023
UNC School of Medicine’s Institute for Global Health & Infectious Diseases has been awarded a $2.9 million grant from the Bill & Melinda Gates Foundation to establish malaria genomic surveillance capacity in the Democratic Republic of Congo (DRC).  Dr. Jonathan Parr is the lead PI, with Dr. Jon Juliano and...

Parr, medical students conduct first study of tocilizumab in treating COVID-19

May 19, 2020
  In the first COVID-19 case series of tocilizumab in the United States, UNC-Chapel Hill researchers report sobering results. They say the drug should be used judiciously until randomized clinical trials determine tocilizumab’s true efficacy. Meanwhile, medical students sidelined from clinical rotations by the virus conducted the research with lightning...